COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 2nd, 2005 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
• SEATTLE GENETICS, INC., a Delaware corporation, having its principal place of business at 21823 30th Drive S.E., Bothell, Washington 98021 (hereinafter referred to as “Licensor”); and
COLLABORATION AGREEMENT by and between SEATTLE GENETICS, INC. and APPLERA CORPORATION through its CELERA GENOMICS GROUPCollaboration Agreement • August 2nd, 2005 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Delaware
THIS COLLABORATION AGREEMENT (this “Agreement”), effective as of July 20, 2004 (the “Effective Date”), is by and between APPLERA CORPORATION, a Delaware corporation, through its CELERA GENOMICS GROUP (“Celera”), having a place of business at 45 West Gude Drive, Rockville, Maryland 20850, and SEATTLE GENETICS, INC., a Delaware corporation (“SGI”), having a place of business at 21823 30th Drive S.E., Bothell, WA 98021.
AMENDMENT NO. 3 TO LICENSE AGREEMENTLicense Agreement • August 2nd, 2005 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
THIS AMENDMENT NO. 3 to License Agreement No. 651-01.LIC (“AMENDMENT NO. 3”), effective as of August 17, 2004 (the “THIRD AMENDMENT DATE”), is entered into by and between Arizona Science & Technology Enterprises d/b/a Arizona Technology Enterprises, an Arizona limited liability company having its principal place of business at 699 S. Mill Avenue, Tempe, AZ 85281 (“AzTE”), acting on behalf of and for THE ARIZONA BOARD OF REGENTS and ARIZONA STATE UNIVERSITY, of Tempe, Arizona (“ASU”) and SEATTLE GENETICS, INC., a corporation organized under the laws of Delaware having its principal place of business located at 21823 30th Drive S.E., Bothell, WA 98021 (“LICENSEE”).
AMENDMENT NO. 2 TO COLLABORATION AGREEMENTCollaboration Agreement • August 2nd, 2005 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Delaware
THIS AMENDMENT NO. 2 to Collaboration Agreement (this “Amendment No. 2”), effective as of August 16, 2004 (the “Second Amendment Date”), is entered into by and between Genencor International, Inc., a Delaware corporation having its principal place of business at 925 Page Mill Road, Palo Alto, CA 94304-1013 (“GCOR”), and Seattle Genetics, Inc., a Delaware corporation having its principal place of business at 21823 30th Drive S.E. Bothell, WA 98021 (“SGI”).
